Quick Financial Statements From 2010 to 2025

QMDT Stock  USD 0.0001  0.00  0.00%   
Analyzing historical trends in various income statement and balance sheet accounts from Quick Med's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Quick Med's valuation are summarized below:
Quick Med Technologies does not presently have any trending fundamental ratios for analysis.
Check Quick Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quick Med's main balance sheet or income statement drivers, such as , as well as many indicators such as . Quick financial statements analysis is a perfect complement when working with Quick Med Valuation or Volatility modules.
  
This module can also supplement various Quick Med Technical models . Check out the analysis of Quick Med Correlation against competitors.

Quick Med Technologies Company Return On Asset Analysis

Quick Med's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Quick Med Return On Asset

    
  -0.35  
Most of Quick Med's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Quick Med Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Quick Med Technologies has a Return On Asset of -0.3521. This is 95.98% lower than that of the Life Sciences Tools & Services sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 151.5% higher than that of the company.

Quick Med Technologies Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Quick Med's current stock value. Our valuation model uses many indicators to compare Quick Med value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Quick Med competition to find correlations between indicators driving Quick Med's intrinsic value. More Info.
Quick Med Technologies is rated fourth in return on asset category among its peers. It is rated fifth in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Quick Med's earnings, one of the primary drivers of an investment's value.

About Quick Med Financial Statements

Quick Med shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Quick Med investors may analyze each financial statement separately, they are all interrelated. The changes in Quick Med's assets and liabilities, for example, are also reflected in the revenues and expenses on on Quick Med's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. The company was founded in 1997 and is headquartered in Gainesville, Florida. Quick-Med Technolog operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Quick Pink Sheet Analysis

When running Quick Med's price analysis, check to measure Quick Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quick Med is operating at the current time. Most of Quick Med's value examination focuses on studying past and present price action to predict the probability of Quick Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quick Med's price. Additionally, you may evaluate how the addition of Quick Med to your portfolios can decrease your overall portfolio volatility.